There have been growing fears across the EU medtech community that the implementation of the new EU Medical Device and In Vitro Diagnostics Regulations (MDR/IVDR) will result in many devices becoming unavailable.
However, this is already a reality for 53% of clinicians, medical specialists and laboratory professionals, according to a recent survey. Regulatory pressures, in addition to other factors such as geopolitical...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?